| Literature DB >> 10348150 |
A Quintás-Cardama1, M Pérez-Encinas, S Gonzalez, A Bendaña, J L Bello.
Abstract
Hydroxyurea is a drug widely used to control myeloproliferative disorders, due in part to its relative lack of severe side effects. We present a case of acute interstitial pneumonitis in a patient who was treated with hydroxyurea for essential thrombocythemia. The clinical course suggests that the interstitial pneumonitis was induced by hydroxyurea. This is the first case of hydroxyurea-induced acute interstitial pneumonitis reported in the literature.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10348150 DOI： 10.1007/s002770050498
Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673